|
|
||||||||
a Department of Thoracic Surgery, Faculty of Medicine, Ataturk University, Turkey
b Department of Anesthesiology, Faculty of Medicine, Ataturk University, Turkey
c Department of Thoracic Surgery, Marasal Cakmak Military Hospital, Erzurum, Turkey
d Department of Thoracic Surgery, Ataturk Training and Research Hospital for Chest Disease and Chest Surgery, Ankara, Turkey
Accepted for publication April 30, 2007.
* Address correspondence to Dr Eroglu, Department of Thoracic Surgery, Faculty of Medicine, Ataturk University, Erzurum, 25240, Turkey (Email: atilaeroglu{at}hotmail.com).
| Abstract |
|---|
|
|
|---|
ng Sytem (LVSS) (Valleylab, Boulder, CO) compared with conventional surgery in esophageal cancer resection. Description: The LVSS (Valleylab) is a device with a hemostatic design frequently used in abdominal surgery. Sixty patients (n = 30 in each group) with esophageal cancer from a single center were evaluated to undergo esophagectomy using either the LVSS or conventional clamping methods. The main outcome measures (ie, operating time, intraoperative blood loss, and postoperative course) were then compared.
Evaluation: In resections performed using the LVSS, operation duration (307 ± 35 minutes vs 260 ± 35 minutes; p = 0.000), intraoperative blood loss (average 533 ± 211 mL vs 390 ± 256 mL; p = 0.022), and postoperative drainage volumes (abdomen, 70 ± 86 mL vs 40 ± 61 mL; p = 0.122; thorax, 690 ± 646 mL vs 540 ± 359 mL; p = 0.271) all decreased.
Conclusions: The LVSS is easy to use and a reliable method in esophageal cancer surgery. Compared with conventional hemostatic techniques a reduction in intraoperative and postoperative blood loss, and a shortening of operation duration were determined. We believe that the use of the LVSS in esophageal surgery will become even more widespread in the future.
| Technology |
|---|
|
|
|---|
|
|
| Technique |
|---|
|
|
|---|
| Clinical Experience |
|---|
|
|
|---|
Anesthesia was performed using a standardized protocol in both groups. With the exception of 4 patients (1 from the LVSS group and 3 from the conventional group), an epidural catheter was implanted in all the patients to provide postoperative analgesia. The LVSS was used in the abdomen in the sealing of all vessels apart from the A. gastrica sinistra and the releasing of the stomach, whereas in the thorax it was used in the releasing of the esophagus in the posterior mediastinum. Two-region lymph node dissection was performed with assistance of the LVSS in all cases. Healthy tissue of at least 7 cm was resected from the tumor proximal and all esophogastric anastomoses were performed with the assistance of staples. The stomach was used for reconstructive purposes in all cases. Postoperatively, one drain was inserted in the splenic lodge in the abdomen and two in the thorax. Operation duration, intraoperative bleeding, postoperative drainage, morbidity and mortality, and length of hospitalization were compared between the two groups in the study.
Statistical Analysis
Comparisons between the two groups were assessed using the independent two-sample t test. Results are expressed as mean values plus standard deviation. Patient characteristics were analyzed by using chi-square test in a 2 x 2 contingency table or Fishers exact test in a 2 x 2 contingency table. Differences were considered significant when p < 0.05. All analyses were performed using SPSS for Windows 12.0 (SPSS Inc, Chicago, IL).
Evaluation
There were a total of 60 patients (27 males [45%] and 33 females [55%] ranging in age from 32 to 80 years). The tumor was localized in the middle thoracic esophagus in 31 patients (52%) and in the lower thoracic esophagus and cardia in 29 patients (48%). Squamous cell carcinoma was determined in 43 patients (71.6%), adenocarcinoma in 15 patients (25%), adenosquamous carcinoma in 1 patient (1.7%), and sarcomatoid carcinoma in 1 patient (1.7%). Three patients (5%) were stage 1, 26 (43%) were stage 2A, 12 (20%) were stage 2B, and 19 (32%) were stage 3 (Table 1).
|
|
| Comment |
|---|
|
|
|---|
There is considerable debate about whether modification of operative techniques (eg, reducing radicality or residual disease) can substantially alter the outcome. Issues that remain particularly controversial are the optimum surgical approach, the extent of lymph node dissection, and the value of using minimally invasive techniques. Although in recent years, postoperative mortality has declined and rates of complete resection have improved, 5-year survival after esophagectomy procedures seldom exceeds 25%. Owing to extensive submucosal lymphatic drainage of the esophagus, nearly 80% of patients who undergo surgery have positive lymph nodes. Nodal involvement is the single most important prognostic factor in esophageal cancer for both locoregional and systemic recurrence after complete resection.
Resection of the esophagus for malignant disease is associated with significant postoperative morbidity and mortality. Surgical technique is an important factor in preventing intraoperative and postoperative complications. The significant factors associated with preoperative complications are intraoperative blood loss, blood transfusion, splenectomy, and prolonged operation time rather than the extent of nodal dissection. In our own experience, one critical point at which splenic injury occurs is when the short gastric vessels are divided.
Blood loss is a well-known risk factor for morbidity and mortality during esophageal and gastric resection; therefore many approaches and devices have been developed to limit bleeding. Surgical hemostasis can be secured by a variety of methods, including mechanical means (sutures) or vessel coagulation (diathermy). Electrocoagulation diathermy is unreliable for vessels larger than 2 mm in diameter [8]. Therefore, suture ligation is preferred for securing larger vascular pedicles. However, this can be time consuming as the pedicles need to be clamped, cut, and ligated. The LVSS is a new hemostatic system based on the combination of pressure and bipolar electrical energy, and it is able to seal vessels up to 7 mm in diameter. The device delivers a controlled high-power current at a low voltage to melt the collagen and elastin in the tissue, leading to permanent fusion of the vascular layers and obliteration of the lumen. The collagen and elastin within the tissue reform to create a "seal zone," which appears as a distinctive, translucent area and has plastic resistance to deformation. In addition, the vessel sealing mechanism produces significantly reduced thermal spread compared with existing bipolar instruments, as energy is automatically switched "off" when tissue impedance reaches a critical level [8]. The current delivered to achieve hemostasis lasts between 2 and 7 seconds, and can thus be relatively faster compared with suture ligation. The LVSS melts the collagen and elastin in the vessel wall to form a seal zone. This process is operator independent, whereas the hemostasis achieved by conventional suture ligation is skill and operator dependent.
Prolonged operating time, excessive blood loss, and splenic injuries contribute to the morbidity associated with gastroesophageal surgery. In our experience, injury to the spleen occurs most frequently when ligating and dividing the short gastric vessels. Anatomically, the intimate relationship between the gastric fundus and the cephaled portion of the spleen contributes to this, whereas the friable and vascular nature of the spleen itself is also a factor. In the 30 cases in which the short gastric vessels were dealt with by standard ligation and division, two splenic injuries occurred. Patient factors are unlikely to have played a role in this, as individual body mass indices were similar in both groups. Our premise was that such a device would have a significant application in open surgery. The longer instrument shaft length allowed for ease of placement, whereas the overlapping rows of staples effectively sealed the vessels. We found the technique particularly helpful in the obese and those with a narrow substernal angle. Gastroesophageal surgery is technically more demanding in such patients, as the vasa brevia to the upper pole of the spleen are obscured by overhanging of the costal margin, and also because of the difficulty in identifying the vessels through the fat of the gastrosplenic omentum and where intraoperative blood loss and transfusion requirements are traditionally greater [9]. Hemorrhage either from the vasa brevia themselves or from iatrogenic splenic injury (occurring at the time of division) is difficult to control, adds significantly to the operating time, and may increase perioperative blood product requirements as demonstrated by the results. Although perioperative allogeneic blood transfusion does not affect long-term survival after esophagogastrectomy for carcinoma, it does have a significant association with short-term survival in a group whose overall survival is often limited after resection [10].
This is the first prospective study to investigate the use of the LVSS device during esophagectomy for esophageal cancer. Our results reveal a mean advantage of 47 minutes in operative time with the use of the LVSS versus the conventional clamp-and-tie technique. The LigaSure Precise vessel sealing instrument (Valleylab, Boulder, CO) is a device that allows for a better approach to the gastric and esophageal vessels, and the operation is feasible through a narrow incision avoiding superfluous manipulations. By shortening the general anesthesia time, the LVSS may also accelerate postoperative recovery. In fact, postoperative stay was shorter with the patients in the LVSS group than the clamp-and-tie group. These results have implications for significant hospital cost savings. No complications related to the use of the LVSS were encountered.
When the use of the LVSS was compared with conventional methods in the Ivor Lewis esophagectomy, operation duration declined by 15% and intraoperative blood loss by 27%. Postoperative drainage volumes also decreased with the LVSS. There was no significant difference in postoperative complications and length of hospital stay, although these were lower in the LVSS group. All freeing of the stomach and esophagus, with the exception of the left gastric vessels, in our cases was performed using the LVSS. No re-suturing in areas cut and sealed using the LVSS was required in any of our cases. All two-region lymph node dissection in the abdomen and thorax was performed using the LVSS. We determined that the use of the LVSS reduced bleeding levels and operation duration in lymph node dissection.
In conclusion, in this initial study, we demonstrated that the use of the LVSS for esophagectomy for esophageal cancer is safe, shortens operative time significantly, and facilitates the operation through a narrow incision. Moreover, application of the LVSS is associated with lower perioperative and postoperative blood loss volume compared with the conventional clamp-and-tie technique.
| Disclosures and Freedom of Investigation |
|---|
|
|
|---|
| Disclaimer |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
T. Gehrig, H. Fonouni, B. P. Muller-Stich, M. Golriz, S. Abbassi, F. Nickel, M. Esmaeilzadeh, K. Brand, M. T. Rad, K. M. Hughes, et al. Comparison of Different Surgical Techniques in Distal Pancreatectomy: An Experimental Study in a Porcine Model Surgical Innovation, December 1, 2011; 18(4): 329 - 337. [Abstract] [PDF] |
||||
![]() |
E. Yekeler, H. Ulutas, C. Becerik, and K. Peker The use of the LigaSureTM in esophagectomy Interact CardioVasc Thorac Surg, July 1, 2010; 11(1): 10 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wright Invited commentary Ann. Thorac. Surg., December 1, 2007; 84(6): 2080 - 2080. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |